LT LISATA THERAPEUTICS, INC. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the LISATA THERAPEUTICS, INC. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 13 January 2026 (Attribution). Among the most active insiders: Buck Kristen K. Every trade is openly available.
Analyst consensus: bullish or bearish? Analysts rate LISATA THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 January 2026
All Executives45 Thresholds0 Prospectus0 Other0
Declarations 45 total
◆ SVP, Bus Dev, General Counsel · Executives · 9 Jan 2026
15,000 shares 0Common Stock SEC:0002055011-26-000003:0
◆ SVP, Fin/Treas, Chief Actg Off · Executives · 9 Jan 2026
15,000 shares 0Common Stock SEC:0002020260-26-000003:0
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001741455-26-000003:0
◆ President & CEO · Executives · 9 Jan 2026
81,000 shares 0Common Stock SEC:0001334549-26-000003:0
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001283301-26-000003:0
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001192621-26-000004:0
● EVP, R&D and CMO · Executives · 9 Jan 2026
2,982 shares @ US$1.97 7.8% of flow Common Stock SEC:0001879231-26-000003:1
● EVP, R&D and CMO · Executives · 9 Jan 2026
3,221 shares @ US$1.97 8.4% of flow Common Stock SEC:0001879231-26-000003:3
● EVP, R&D and CMO · Executives · 9 Jan 2026
2,147 shares @ US$1.97 5.6% of flow Common Stock SEC:0001879231-26-000003:4
● EVP, R&D and CMO · Executives · 9 Jan 2026
2,982 shares @ US$1.97 7.8% of flow Common Stock SEC:0001879231-26-000003:2
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001309653-26-000004:0
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001373585-26-000003:0
◆ EVP, R&D and CMO · Executives · 9 Jan 2026
25,000 shares 0Common Stock SEC:0001879231-26-000003:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001283301-25-000002:0
◆ EVP, R&D and CMO · Executives · 9 Jan 2025
25,000 shares 0Common Stock SEC:0001879231-25-000002:0
◆ SVP, Fin/Treas, Chief Actg Off · Executives · 9 Jan 2025
15,000 shares 0Common Stock SEC:0002020260-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001741455-25-000002:0
◆ President & CEO · Executives · 9 Jan 2025
81,000 shares 0Common Stock SEC:0001334549-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001373585-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001309653-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001192621-25-000002:0
◆ EVP, R&D and CMO · Executives · 1 Oct 2024
15,000 shares @ US$2.93 61.4% of flow Common Stock SEC:0001879231-24-000004:0
◆ President & CEO · Executives · 1 Oct 2024
58,000 shares @ US$2.93 95.5% of flow Common Stock SEC:0001334549-24-000006:0
◆ SVP, Fin/Treas, Chief Actg Off · Executives · 1 Oct 2024
3,300 shares @ US$2.93 100.0% of flow Common Stock SEC:0002020260-24-000002:0
● Chief Executive Officer · Executives · 11 Jan 2024
1,026 shares @ US$2.99 1.7% of flow Common Stock SEC:0001334549-24-000004:0
25 of 45 declarations
Load more (20 remaining) About LISATA THERAPEUTICS, INC. LISATA THERAPEUTICS, INC. is a company focused on developing innovative therapies for the treatment of diseases. It is listed on the XNAS market.